Product ID:862 3217,DOT WORKS MAJESTIC 550 RAPID ACCESS DEVELOPER
MSDS Date:01/21/1998
FSC:NIIN:Submitter:D DG
Status Code:A
MSDS Number: CKRRJ

EASTMAN KODAK COMPANY

343 STATE STREET
ROCHESTER, NY 14650
US

Emergency Phone: 716 722-5151

Info Phone: 716-722-5151/(800) 242-2424

Cage: 19139

EASTMAN KODAK CO GOVERNMENT MARKETS CONTRACTS

ROCHESTER, NY 14650-1115 US

Telephone: 716-722-5151/(800) 242-2424

Cage: 19139

WATER

CAS: 7732-18-5

RTECS: ZC0110000

POTASSIUM SULFITE

CAS: 10117-38-1

SODIUM SULFITE

CAS: 7757-83-7

RTECS: WE2150000

HYDROQUINONE

CAS: 123-31-9

RTECS: MX3500000

OSHA PEL 2 MG/M3

ACGIH TLV: 2 MG/M3

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

POTASSIUM CARBONATE

CAS: 584-08-7

RTECS: TS7750000

SODIUM HYDROXIDE

CAS: 1310-73-2

RTECS: WB4900000

OSHA PEL 2 MG/M3

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

POTASSIUM HYDROXIDE

CAS: 1310-58-3

RTECS: TT2100000

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION-EXPECTED TO BE A LOW HAZARD
FOR RECOMMENDED HANDLING. IN CONTACT WITH STRONG ACIDS OR IF
HEATED, SULFITES MAY LIBERATE SULFUR DIOXIDE GAS WHICH IS
IRRITATING TO RESPIRATORY TRACT. SOME ASTH MATICS OR HYPERSENSITIVE
INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING. EYES-CAUSES
IRRITATION. SKIN-CAUSES IRRITATION. MAY CAUSE ALLERGIC SKIN
REACTION BASED ON HUMAN EXPERIENCE. MAY CAUSE SKIN DEPI GMENTATION.
INGESTION-HARMFUL IF SWALLOWED. MAY CAUSE IRRITATION OF THE
GASTROINTESTINAL TRACT.
Explanation of Carcinogenicity:CARCINOGENICITY CLASSIFICATION
(COMPONENTS PRESENT AT 0.1% OR MORE): INTERNATIONAL AGENCY FOR
RESEARCH ON CANCER (IARC): NONE. AMERICAN CONFERENCE OF
GOVERNMENTAL INDUSTRIAL HYGIENISTS (ACGIH): NONE. NATIONAL
TOXICOLOGY PROGRAM (NTP): NONE. OCCUPATIONAL SAFETY AND HEALTH
ADMINISTRATION (OSHA): NONE.
Effects of Overexposure:SOME ASTHMATICS OR SULFITE-SENSITIVE
INDIVIDUALS MAY EXPERIENCE WHEEZING, CHEST TIGHTNESS, STOMACH
UPSET, HIVES, FAINTNESS, WEAKNESS, DIARRHEA.
Medical Cond Aggravated by Exposure: SOME ASTHMATICS OR HYPERSENSITIVE
INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING.

First Aid:INHALATION-IF SYMPTOMATIC, MOVE TO FRESH AIR. TREAT
SYMPTOMATICALLY. GET MEDICAL AID IF SYMPTOMS PERSIST.
EYES-IMMEDIATELY FLUSH WITH PLENTY OF WATER FOR 15 MINS. GET
MEDICAL AID. SKIN-IMMEDIATELY FLU SH WITH PLENTY OF WATER FOR 15
MINS WHILE REMOVING CONTAMINATED CLOTHING & SHOES. IF SKIN
IRRITATION OR AN ALLERGIC SKIN REACTION DEVELOPS, GET MEDICAL AID.
WASH CONTAMINATED CLOTHING BEFORE REUSE. DE STROY OR THOROUGHLY
CLEAN CONTAMINATED SHOES. INGESTION-ONLY INDUCE VOMITING AT THE
INSTRUCTION OF MEDICAL PERSONNEL. CALL A PHYSICIAN/POISON CONTROL
CENTER. NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSC IOUS PERSON.
CALL A PHYSICIAN OR

Flash Point:NONE
Extinguishing Media:USE APPROPRIATE AGENT FOR ADJACENT FIRE.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
PROTECTIVE CLOTHING. FIRE OR EXCESSIVE HEAT MAY PRODUCE HAZARDOUS
DECOMPOSITION PRODUCTS.
Unusual Fire/Explosion Hazard:NONE

Spill Release Procedures:FLUSH TO SEWER WITH LARGE AMOUNTS OF WATER.
OTHERWISE, ABSORB SPILL WITH VERMICULITE OR OTHER INERT MATERIAL,
THEN PLACE IN A CONTAINER FOR CHEMICAL WASTE. CLEAN SURFACE
THOROUGHLY TO REMOVE RESIDUAL CONTAMINATION.

Handling and Storage Precautions:KEEP CONTAINER CLOSED. KEEP AWAY FROM
INCOMPATIBLE SUBSTANCES.
Other Precautions:AVOID BREATHING MIST OR VAPOR. AVOID CONTACT WITH
EYES, SKIN, AND CLOTHING. USE WITH ADEQUATE VENTILATION. WASH
THOROUGHLY AFTER HANDLING. THE ROUTINE USE OF A NONALKALINE (ACID)
TYPE OF HAND CLEANER & REGULAR CLEANING OF WORKING SURFACES,
GLOVES, ETC. WILL HELP MINIMIZE THE POSSIBILITY OF A SKIN RE
ACTION.

Respiratory Protection:NONE SHOULD BE NEEDED. NONE SHOULD BE NEEDED. A
RESPIRATOR SHOULD BE WORN IF HAZARDOUS DECOMPOSITION PRODUCTS ARE
LIKELY TO BE OR HAVE BEEN RELEASED. RESPIRATOR TYPE: ACID GAS. SEE
STABILITY AND REACT IVITY SECTION. IF RESPIRATORS ARE USED, A
PROGRAM SHOULD BE INSTITUTED TO ASSURE COMPLIANCE WITH OSHA
STANDARD 29 CFR 1910.134.
Ventilation:GOOD GENERAL VENTILATION (TYPICALLY 10 AIR CHANGES PER
HOUR) SHOULD BE USED. VENTILATION RATES SHOULD BE MATCHED TO
CONDITIONS.
Protective Gloves:WEAR IMPERVIOUS GLOVES AND PROTECTIVE CLOTHING
APPROPRIATE FOR RISK OF EXPOSURE
Eye Protection:WEAR SAFETY GLASSES WITH SIDE SHIELDS (OR GOGGLES).
Other Protective Equipment:EYE BATH, WASHING FACILITIES, SAFETY SHOWER.
Work Hygienic Practices:WASH CONTAMINATED CLOTHING BEFORE RESUE.
DESTROY OR THOROUGHLY CLEAN CONTAIMINATED SHOES.
Supplemental Safety and Health
SUPPLEMENTARY LOCAL EXHAUST VENTILATION, CLOSED SYSTEMS, OR RESPIRATORY
PROTECTION MAY BE NEEDED IN SPECIAL CIRCUMSTANCES SUCH AS POORLY
VENTILATED SPACES, MECHANICAL GENERATION OF DUSTS, HEATING, DRY
ING, ETC.

HCC:B3
Boiling Pt:B.P. Text:NOT AVAILABLE
Vapor Pres:NOT AVAILABLE
Vapor Density:0.6
Spec Gravity:1.094
pH:10.5
Solubility in Water:COMPLETE
Appearance and Odor:LIGHT YELLOW LIQUID. ODOR: ODORLESS.
Percent Volatiles by Volume:85-90% WT

Stability Indicator/Materials to Avoid:YES
STRONG ACIDS.
Stability Condition to Avoid:STABLE
Hazardous Decomposition Products:SULFUR DIOXIDE.
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Waste Disposal Methods:DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT
TO NATIONAL, STATE, OR LOCAL LAWS. FLUSH TO SEWER WITH LARGE
AMOUNTS OF WATER. SINCE EMPTIED CONTAINERS RETAIN PRODUCT RESIDUE,
FOLLOW LABEL WARNINGS E VEN AFTER CONTAINER IS EMPTIED.

Toxicological Information:GENERAL: CONTAINS HYDROQUINONE. IN F-344
RATS, CHRONOC ORAL ADMINISTRATION OF HYDROQUINONE HAS RESULTED IN
THE FORMATION OF BENIGN KIDNEY TUMORS THOUGHT TO BE SECONDARY TO
NEPHROPATHY. HYSROQUINONE-IN DUCED NEPHROPATHY FOLLOWING
ADMINISTRATION HAS BEEN NOTED IN THE MALE F-344 RAT, BUT NOT IN
OTHER SPECIES OR RAT STRAINS TESTED. ALTHOUGH AN INCREASE IN
MONONUCLEAR CELL LEUKEMIA IN F-344 FEMALE RATS HAS BEEN REPORTED
FOLLOWING CHRONIC ORAL ADMINISTRATION OF HYDROQUINONE, THIS FINDING
WAS NOT REPRODUCED IN A SUBSEQUENT STUDY.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:DATA FOR THE MAJOR COMPONENTS OF THIS MATERIAL HAVE BEEN
USED TO ESTIMATE THE ENVIRONMENTAL IMPACT OF THIS MATERIAL.
HOWEVER, THIS MATERIAL, ITSELF, HAS NOT BEEN TESTED FOR
ENVIRONMENTAL EFFECTS. THIS MATERIAL IS A MODERATELY ALKALINE
AQUEOUS SOLUTION, AND THIS PROPERTY MAY CAUSE ADVERSE ENVIRONMENTAL
EFFECTS. IT IS EXPECTED TO HAVE THE FOLLOWING PROPERTIES: A LOW
BIOCHEMICAL OXYGEN DEMAND & LITTL E POTENTIAL TO CAUSE OXYGEN
DEPLETION IN AQUEOUS SYSTEMS, A HIGH POTENTIAL TO AFFECT SOME
AQUATIC ORGANISMS, AMODERATE POTENTIAL TO AFFECT SECONDARY WASTE
TREATMENT MICROBIAL METABOLISM.

Transport Information:FOR TRANSPORTATION INFORMATION REDARDING THIS
PRODUCT CALL THE KODAK WORLDWIDE TRANSPORTATION HAZMAT HOTLINE:
(716) 722-2400 BETWEEN 8 A.M. AND 5 P.M. (EASTERN STANDARD TIME),
MONDAY THROUGH FRIDAY.

SARA Title III Information:HYDROQUINONE.
State Regulatory Information:NONE.